CLINICAL TRIALS PROFILE FOR PEGASPARGASE
✉ Email this page to a colleague
All Clinical Trials for pegaspargase
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002590 ↗ | Combination Chemotherapy in Treating Children With Lymphoma | Completed | National Cancer Institute (NCI) | Phase 2 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children who have lymphoma. |
| NCT00002590 ↗ | Combination Chemotherapy in Treating Children With Lymphoma | Completed | Children's Oncology Group | Phase 2 | 1994-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating children who have lymphoma. |
| NCT00002744 ↗ | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia | Completed | National Cancer Institute (NCI) | Phase 3 | 1996-05-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more cancer cells. It is not yet known which regimen of combination chemotherapy is more effective for acute lymphoblastic leukemia PURPOSE: Randomized phase III trial to compare different regimens of combination chemotherapy in treating children who have newly diagnosed acute lymphoblastic leukemia. |
| NCT00002744 ↗ | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia | Completed | Children's Oncology Group | Phase 3 | 1996-05-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug and giving them in different ways may kill more cancer cells. It is not yet known which regimen of combination chemotherapy is more effective for acute lymphoblastic leukemia PURPOSE: Randomized phase III trial to compare different regimens of combination chemotherapy in treating children who have newly diagnosed acute lymphoblastic leukemia. |
| NCT00002766 ↗ | Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma | Completed | National Cancer Institute (NCI) | Phase 3 | 1996-03-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which regimen of combination chemotherapy is more effective for acute lymphoblastic leukemia, lymphoblastic lymphoma, or chronic myelogenous leukemia. PURPOSE: This randomized phase III trial is studying two different chemotherapy regimens and comparing them to see how well they work in treating adults with acute lymphoblastic leukemia, lymphoblastic lymphoma, or chronic myelogenous leukemia. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for pegaspargase
Condition Name
Clinical Trial Locations for pegaspargase
Trials by Country
Clinical Trial Progress for pegaspargase
Clinical Trial Phase
Clinical Trial Sponsors for pegaspargase
Sponsor Name
